Not yet recruitingInterventionalNot ApplicableLast updated Aug 11, 2026

Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) Embolization

Overview

ClinicalTrials.gov ID: NCT07757113
Lead Sponsor: Sanford HealthOTHER
Brief Summary: Single site, prospective, comparative effectiveness pilot trial comparing efficacy and safety outcomes of three embolic materials (particles, liquid embolics, and Wallaby Phenox coils) in MMA embolication for cSDH.
Study Type: Interventional

Status

Study Record Dates

NCT04095819Unknown status

Middle Meningeal Artery (MMA) Embolization Compared to Traditional Surgical Strategies to Treat Chronic Subdural Hematomas (cSDH)

NCT03307395Completed

Middle Meningeal Artery Embolization for Treatment of Chronic Subdural Hematoma

NCT04574843Unknown status

Middle Meningeal Artery Embolization With Liquid Embolic Agent for Treatment of Chronic Subdural Hematoma

NCT04270955Completed

Dartmouth Middle Meningeal Embolization Trial (DaMMET)

NCT04065113Withdrawn

Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

NCT06347796Recruiting

Chronic Subdural Hematoma Treatment With Embolization Versus Surgery Study